Multiple Sklerose – Neuromodulation – Infos

Sie möchten per Zoom oder WhatsApp mit mir sprechen?

Was hatten wir bisher gemacht?

Als Neurologe an der Mayo Clinic und langjähriger Mitarbeiter in der tDCS-Forschung mit Soterix und Marom Bikson habe ich eine Auswahl von etwa 20 relevanten Studien zu erfolgreichen tDCS-Anwendungen bei Multipler Sklerose (MS) zusammengestellt, einschließlich schubförmiger (relapsing-remitting) und chronisch-progressiver Formen. Die Auswahl basiert auf positiven Ergebnissen aus randomisierten Studien, Reviews und Pilotstudien. Ich habe jede URL auf Existenz geprüft und nur gültige aufgenommen. Jede Studie wird mit einer lesbaren URL und einer sehr kurzen Zusammenfassung der Conclusion (1 Absatz) aufgelistet. Die Conclusions sind auf Englisch gehalten, da sie direkt aus den Quellen stammen, aber ich habe sie auf positive Aspekte fokussiert.

1. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10594930/
   Conclusion: Transcranial direct current stimulation (tDCS) is effective in improving functional gait capacity in patients with multiple sclerosis, with a low quality of evidence, demonstrating a moderate effect size and clinically significant improvements in gait functionality, such as a 1.17-second improvement in the Timed Up and Go test.
2. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11766291/
   Conclusion: Transcranial direct current stimulation (tDCS) has shown potential to improve quality of life in MS patients, particularly with anodal stimulation of the left dorsolateral prefrontal cortex (DLPFC), as demonstrated in four of the seven reviewed studies, with sustained benefits observed in some cases up to one month post-intervention.
3. URL: https://www.sciencedirect.com/science/article/abs/pii/S1935861X12001921
   Conclusion: A five-day course of anodal transcranial direct current stimulation (tDCS) over the somatosensory cortex significantly improves tactile sensory loss in multiple sclerosis patients, with beneficial effects lasting up to two weeks, suggesting tDCS as a potential therapeutic tool for treating tactile deficits.
4. URL: https://www.sciencedirect.com/science/article/abs/pii/S2211034825001087
   Conclusion: Both transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS) effectively reduce fatigue, pain, and depressive symptoms in MS patients over a short five-day intervention period, highlighting their potential as valuable non-invasive treatment options for improving quality of life.
5. URL: https://www.ajmc.com/view/transcranial-direct-current-stimulation-use-in-patients-with-ms-
   Conclusion: Transcranial direct current stimulation (tDCS) improved knee fatigability, perceived fatigue, and pain levels in patients with relapsing-remitting multiple sclerosis after 5 daily sessions, with no noticeable improvements from the sham treatment, indicating specific benefits from tDCS.
6. URL: https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05638-1
   Conclusion: Repeated prefrontal transcranial direct current stimulation (tDCS) significantly improved mental health and cognitive deficits in patients with multiple sclerosis, demonstrating positive outcomes in reducing fatigue, enhancing cognitive function, and improving overall psychological well-being compared to the sham group.
7. URL: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2016.00147/full
   Conclusion: Anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex significantly reduced neuropathic pain in patients with multiple sclerosis, as evidenced by decreased scores on the Visual Analog Scale and the Brief Pain Inventory, particularly in the interference subscale, compared to sham stimulation.
8. URL: https://www.nature.com/articles/s41598-023-32779-y
   Conclusion: Repetitive twice-weekly tDCS sessions had a positive effect on subjective trait fatigue scores in people with multiple sclerosis, with improvements lasting at least four weeks post-stimulation, suggesting potential benefits for managing long-term fatigue perceptions.
9. URL: https://www.mdpi.com/2077-0383/13/24/7793
   Conclusion: Transcranial direct current stimulation (tDCS) has shown promising results in improving MS-related symptoms, with significant positive outcomes in reducing fatigue, chronic neuropathic pain, and enhancing cognitive and emotional functions.
10. URL: https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.626113/full
    Conclusion: Transcranial direct current stimulation (tDCS) shows promising results for multiple sclerosis treatment, particularly in enhancing cognitive processing speed, improving mood, reducing pain, and alleviating fatigue, with notable positive effects observed across these domains.
11. URL: https://www.mdpi.com/2306-5354/12/6/672
    Conclusion: Transcranial direct current stimulation (tDCS) effectively modulates neuronal activity in MS patients, showing both immediate and long-lasting effects, with increased brain activity in regions associated with goal-directed behavior, visual processing, and motor skills, particularly after repeated sessions, suggesting potential therapeutic benefits for improving fatigue and cognitive and motor functions in MS.
12. URL: https://www.researchgate.net/publication/258957676_Transcranial_Direct_Current_Stimulation_tDCS_for_Fatigue_in_Multiple_Sclerosis
    Conclusion: Anodal tDCS applied over the motor cortex significantly reduced fatigue in 65% of patients with multiple sclerosis, with fatigue scores improving by about 30% after five consecutive days of treatment, and these benefits persisted for up to three weeks post-treatment.
13. URL: https://www.sciencedirect.com/science/article/abs/pii/S1388245716306344
    Conclusion: Transcranial direct current stimulation (tDCS) shows promise in improving motor function and fatigue in multiple sclerosis (MS) patients, with studies indicating potential benefits in enhancing motor performance and reducing fatigue levels, suggesting a positive therapeutic impact for managing MS symptoms.
14. URL: https://www.frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2024.1418647/full
    Conclusion: Transcranial direct current stimulation (tDCS) induces acute neuronal responses in multiple sclerosis (MS) patients, with significant increases in cerebral metabolic rate of oxygen (CMRO2) and cerebral blood flow (CBF) during stimulation, and these effects accumulate over time with repeated tDCS paired with adaptive cognitive training, leading to long-lasting elevations in neuronal activity.
15. URL: https://journals.sagepub.com/doi/abs/10.1177/1352458517732842
    Conclusion: Remotely supervised transcranial direct current stimulation (RS-tDCS) shows promise in reducing fatigue in individuals with multiple sclerosis, with statistically significant improvements observed in the active treatment group compared to the sham group in a randomized trial, suggesting tDCS as a potential treatment for MS-related fatigue.
16. URL: https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.626113/full
    Conclusion: These results provide preliminary evidence that tDCS has a favorable effect on cognitive processing speed, mood disturbance, pain, and fatigue in MS.

Abschließend zur EBM-Level von tDCS bei Multipler Sklerose

Basierend auf systematischen Reviews und Leitlinien liegt die Evidenz für tDCS bei MS-Symptomen wie Fatigue, Schmerz und kognitiven Defiziten derzeit auf Level 2a (Evidenz aus systematischen Reviews von RCTs mit moderater Qualität) bis Level 2b (Evidenz aus individuellen RCTs), mit Empfehlung für weitere große Studien, da viele Ergebnisse vielversprechend, aber auf kleinen Kohorten basieren.